Works matching IS 00071188 AND DT 2024 AND VI 181 AND IP 22

Results: 19

Preface to the Review Series Neuropharmacology of addiction.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4383, doi. 10.1111/bph.17339

By:

Lawrence, Andrew J.;
Langmead, Christopher J.

Publication type:

Article

Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4430, doi. 10.1111/bph.17325

By:

Mohammadkhani, Aida;
Mitchell, Caitlin;
James, Morgan H.;
Borgland, Stephanie L.;
Dayas, Christopher V.

Publication type:

Article

Advancing the field of viroporins—Structure, function and pharmacology: IUPHAR Review 39.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4450, doi. 10.1111/bph.17317

By:

Devantier, Kira;
Kjær, Viktoria M. S.;
Griffin, Stephen;
Kragelund, Birthe B.;
Rosenkilde, Mette M.

Publication type:

Article

Biased receptor signalling and intracellular trafficking profiles of structurally distinct formylpeptide receptor 2 agonists.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4677, doi. 10.1111/bph.17310

By:

Peng, Cheng;
Vecchio, Elizabeth A.;
Nguyen, Anh T. N.;
De Seram, Mia;
Tang, Ruby;
Keov, Peter;
Woodman, Owen L.;
Chen, Yung‐Chih;
Baell, Jonathan;
May, Lauren T.;
Zhao, Peishen;
Ritchie, Rebecca H.;
Qin, Cheng Xue

Publication type:

Article

The protein disulfide isomerase A3 and osteopontin axis promotes influenza‐induced lung remodelling.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4610, doi. 10.1111/bph.16511

By:

Kumar, Amit;
Mark, Zoe F.;
Carbajal, Morgan P.;
DeLima, Dhemerson Souza;
Chamberlain, Nicolas;
Walzer, Joseph;
Ruban, Mona;
Chandrasekaran, Ravishankar;
Daphtary, Nirav;
Aliyeva, Minara;
Poynter, Matthew E.;
Janssen‐Heininger, Yvonne M. W.;
Bates, Jason H.;
Alcorn, John F.;
Britto, Clemente J.;
Dela Cruz, Charles S.;
Jegga, Anil G.;
Anathy, Vikas

Publication type:

Article

SCA44‐ and SCAR13‐associated GRM1 mutations affect metabotropic glutamate receptor 1 function through distinct mechanisms.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4514, doi. 10.1111/bph.16510

By:

Wang, Yuyang;
Muraleetharan, Ashwin;
Langiu, Monica;
Gregory, Karen J.;
Hellyer, Shane D.

Publication type:

Article

Interleukin‐1 receptor‐associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll‐like receptors 4 and 7/8 in murine and human lungs.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4647, doi. 10.1111/bph.16509

By:

Sayers, Ian;
Thakker, Dhruma;
Billington, Charlotte;
Kreideweiss, Stefan;
Grundl, Marc A.;
Bouyssou, Thierry;
Thamm, Sven;
Kreuz, Sebastian;
Hall, Ian P.

Publication type:

Article

In silico and biological analyses of missense variants of the human biliary efflux transporter ABCC2: effects of novel rare missense variants.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4593, doi. 10.1111/bph.16508

By:

Kölz, Charlotte;
Gaugaz, Fabienne Z.;
Handin, Niklas;
Schaeffeler, Elke;
Tremmel, Roman;
Winter, Stefan;
Klein, Kathrin;
Zanger, Ulrich M.;
Artursson, Per;
Schwab, Matthias;
Nies, Anne T.

Publication type:

Article

The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4531, doi. 10.1111/bph.16507

By:

Kamath, Srinivas;
Hunter, Alexander;
Collins, Kate;
Wignall, Anthony;
Joyce, Paul

Publication type:

Article

Sex differences in the effects of N‐ethylpentylone in young CD1 mice: Insights on behaviour, thermoregulation and early gene expression.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4491, doi. 10.1111/bph.16506

By:

Espinosa‐Velasco, María;
Castro‐Zavala, Adriana;
Reguilón, Marina D.;
Gallego‐Landin, Inés;
Bellot, Marina;
Rublinetska, Olga;
Valverde, Olga;
Rodríguez‐Arias, Marta;
Nadal‐Gratacós, Núria;
Berzosa, Xavier;
Gómez‐Canela, Cristian;
Carbó, Marcel·lí;
Camarasa, Jorge;
Escubedo, Elena;
López‐Arnau, Raúl;
Pubill, David

Publication type:

Article

Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4628, doi. 10.1111/bph.16505

By:

Ruixin, Sun;
Yifan, Liu;
Yansha, Sun;
Min, Zhou;
Yiwei, Dong;
Xiaoli, Hu;
Bizhi, Shi;
Hua, Jiang;
Zonghai, Li

Publication type:

Article

The role of venous capacity in fluid retention with endothelin A antagonism: Mathematical modelling of the RADAR trial.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4693, doi. 10.1111/bph.16504

By:

Yu, Hongtao;
Greasley, Peter J.;
Lambers Heerspink, Hiddo J.;
Ambery, Philip;
Ahlstrom, Christine;
Hamren, Bengt;
Khan, Anis A.;
Boulton, David W.;
Hallow, K. Melissa

Publication type:

Article

Impacts of exposure to and subsequent discontinuation of clozapine on tripartite synaptic transmission.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4571, doi. 10.1111/bph.16503

By:

Okada, Motohiro;
Fukuyama, Kouji;
Motomura, Eishi

Publication type:

Article

NL13, a novel curcumin analogue and polo like kinase 4 inhibitor, induces cell cycle arrest and apoptosis in prostate cancer models.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4658, doi. 10.1111/bph.16501

By:

Qiao, Xinyi;
Zheng, Ke;
Ye, Lei;
Yang, Jin;
Cui, Rong;
Shan, Yuanyuan;
Li, Xiaoheng;
Li, Huitao;
Zhu, Qiqi;
Zhao, Zhiguang;
Ge, Ren‐shan;
Wang, Yiyan

Publication type:

Article

Blockade of CaV3 calcium channels and induction of G0/G1 cell cycle arrest in colon cancer cells by gossypol.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4546, doi. 10.1111/bph.16497

By:

Lopez‐Charcas, Osbaldo;
Benouna, Oumnia;
Lemoine, Roxane;
Rosendo‐Pineda, Margarita Jacaranda;
Anguheven‐Ledezma, Tonantzin Guadalupe;
Sandoval‐Vazquez, Lizeth;
Gallegos‐Gomez, Martin Leonardo;
Robles‐Martinez, Leticia;
Herrera‐Carrillo, Zazil;
Ramírez‐Aragón, Miguel;
Alfaro, Ana;
Chadet, Stéphanie;
Ferro, Fabio;
Besson, Pierre;
Jiang, Lin‐Hua;
Velu, Sadanandan E.;
Guerrero‐Hernandez, Agustín;
Roger, Sébastien;
Gomora, Juan Carlos

Publication type:

Article

Molecular and structural insights into the 5‐HT2C receptor as a therapeutic target for substance use disorders.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4414, doi. 10.1111/bph.16233

By:

Ubhayarathna, Maleesha;
Langmead, Christopher J.;
Diepenhorst, Natalie A.;
Stewart, Gregory D.

Publication type:

Article

G protein‐coupled receptor modulation of striatal dopamine transmission: Implications for psychoactive drug effects.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4399, doi. 10.1111/bph.16151

By:

Littlepage‐Saunders, Mydirah;
Hochstein, Michael J.;
Chang, Doris S.;
Johnson, Kari A.

Publication type:

Article

Issue Information.

Published in:: British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4381, doi. 10.1111/bph.16137
Publication type:: Article

Targeting muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development.

Published in:

British Journal of Pharmacology, 2024, v. 181, n. 22, p. 4385, doi. 10.1111/bph.16081

By:

Walker, Leigh C.;
Huckstep, Kade L.;
Becker, Howard C.;
Langmead, Christopher J.;
Lawrence, Andrew J.

Publication type:

Article

Works matching IS 00071188 AND DT 2024 AND VI 181 AND IP 22

Preface to the Review Series Neuropharmacology of addiction.

Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation.

Advancing the field of viroporins—Structure, function and pharmacology: IUPHAR Review 39.

Biased receptor signalling and intracellular trafficking profiles of structurally distinct formylpeptide receptor 2 agonists.

The protein disulfide isomerase A3 and osteopontin axis promotes influenza‐induced lung remodelling.

SCA44‐ and SCAR13‐associated GRM1 mutations affect metabotropic glutamate receptor 1 function through distinct mechanisms.

Interleukin‐1 receptor‐associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll‐like receptors 4 and 7/8 in murine and human lungs.

In silico and biological analyses of missense variants of the human biliary efflux transporter ABCC2: effects of novel rare missense variants.

The atypical antipsychotics lurasidone and olanzapine exert contrasting effects on the gut microbiome and metabolic function of rats.

Sex differences in the effects of N‐ethylpentylone in young CD1 mice: Insights on behaviour, thermoregulation and early gene expression.

Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer.

The role of venous capacity in fluid retention with endothelin A antagonism: Mathematical modelling of the RADAR trial.

Impacts of exposure to and subsequent discontinuation of clozapine on tripartite synaptic transmission.

NL13, a novel curcumin analogue and polo like kinase 4 inhibitor, induces cell cycle arrest and apoptosis in prostate cancer models.

Blockade of Ca<sub>V</sub>3 calcium channels and induction of G<sub>0</sub>/G<sub>1</sub> cell cycle arrest in colon cancer cells by gossypol.

Molecular and structural insights into the 5‐HT<sub>2C</sub> receptor as a therapeutic target for substance use disorders.

G protein‐coupled receptor modulation of striatal dopamine transmission: Implications for psychoactive drug effects.

Issue Information.

Targeting muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development.